Robert Hammond
Impact in
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
- COVID-19 Clinical Research Studies
-
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 12
- Mycobacterium research and diagnosis 6
-
- Tuberculosis Research and Epidemiology 5
- COVID-19 Clinical Research Studies 5
- Co-authors
- Stephen H. Gillespie (15 shared papers)Samuel Lipworth (3 shared papers)Anthony Coates (7 shared papers)Yanmin Hu (1 shared paper)Kishan Dholakia (2 shared papers)Katarína Oravcová (1 shared paper)Mingzhou Chen (2 shared papers)Robert E. Sherman (1 shared paper)
- Journals
- Journal of Medical Microbiology (4 papers)Scientific Reports (3 papers)Tuberculosis (2 papers)Biomedicines (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)
- Partner nations
- United KingdomUnited StatesSouth Korea
In The Last Decade
Robert Hammond
26 papers receiving 272 citations
Peers
Comparison fields: 5 of 85
- Infectious Diseases 131
- Molecular Medicine 30
- Biophysics 29
- Clinical Biochemistry 23
- Epidemiology 101
Countries citing papers authored by Robert Hammond
This map shows the geographic impact of Robert Hammond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Hammond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Hammond more than expected).
Fields of papers citing papers by Robert Hammond
This network shows the impact of papers produced by Robert Hammond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Hammond. The network helps show where Robert Hammond may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Hammond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 65 | |
| 2 | 2015 | 38 | |
| 3 | 2020 | 33 | |
| 4 | 2017 | 21 | |
| 5 | 1980 | 19 | |
| 6 | 2019 | 17 | |
| 7 | 2023 | 14 | |
| 8 | 2023 | 11 | |
| 9 | Water-related disease in Florida: continuing threats require vigilance. | 1997 | 7 |
| 10 | 2020 | 6 | |
| 11 | 2023 | 6 | |
| 12 | 2023 | 5 | |
| 13 | 2018 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2018 | 4 | |
| 17 | Identity Theft: How to Protect Your Most Valuable Asset | 2003 | 4 |
| 18 | 2019 | 3 | |
| 19 | 2023 | 2 | |
| 20 | 2024 | 2 |
About Robert Hammond
Robert Hammond is a scholar working on Epidemiology, Infectious Diseases, Clinical Biochemistry, Surgery and Pharmacology, having authored 31 papers that have together received 277 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (9 papers), Mycobacterium research and diagnosis (6 papers), Tuberculosis Research and Epidemiology (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), COVID-19 Clinical Research Studies (5 papers), Antibiotic Resistance in Bacteria (3 papers), Spectroscopy Techniques in Biomedical and Chemical Research (3 papers) and Diagnosis and treatment of tuberculosis (3 papers). The work is most often cited by research in Infectious Diseases (131 citations), Molecular Medicine (30 citations), Biophysics (29 citations), Clinical Biochemistry (23 citations) and Epidemiology (101 citations). Robert Hammond has collaborated with scholars based in United Kingdom, United States and South Korea. Frequent co-authors include Stephen H. Gillespie, Samuel Lipworth, Anthony Coates, Yanmin Hu, Kishan Dholakia, Katarína Oravcová, Mingzhou Chen, Robert E. Sherman, David W. Johnson and Peter Glynne‐Jones. Their work appears in journals such as Journal of Medical Microbiology, Scientific Reports, Tuberculosis, Biomedicines and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.